Puja Gupta

发表

Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells.

W. Guida, K. Daniel, Q. Dou, 2004, Biochemical pharmacology.

Development of an EGFRvIII specific recombinant antibody

Shuang-yin Han, S. Mitra, Gordon Li, 2010, BMC biotechnology.

Potential molecular targets of tea polyphenols in human tumor cells: significance in cancer prevention.

K. Daniel, Q. Dou, Aslamuzzaman Kazi, 2002, In vivo.

Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III.

K. Jensen, H. Vogel, Shuang-yin Han, 2014, Cancer research.

Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III.

K. Jensen, H. Vogel, Shuang-yin Han, 2014, Cancer Research.

Stromal Platelet-Derived Growth Factor Receptor α (PDGFRα) Provides a Therapeutic Target Independent of Tumor Cell PDGFRα Expression in Lung Cancer Xenografts

M. Peyton, D. Gerber, R. Brekken, 2012, Molecular Cancer Therapeutics.

Preclinical Development Stromal Platelet-Derived Growth Factor Receptor a ( PDGFR a ) Provides a Therapeutic Target Independent of Tumor Cell PDGFR a Expression in Lung Cancer Xenografts

M. Peyton, D. Gerber, R. Brekken, 2012 .

Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer.

J. Minna, C. Roland, N. Bardeesy, 2010, Cancer research.

Methodologic Considerations in the Application of Next-Generation Sequencing of Human TRB Repertoires for Clinical Use.

P. Lavori, J. Zehnder, E. Meyer, 2017, The Journal of molecular diagnostics : JMD.

Late effects in adult survivors of pediatric cancer: a guide for the primary care physician.

Puja Gupta, Lisa M. Kopp, Luz Pelayo-Katsanis, 2012, The American journal of medicine.

Abstract 3733: Defining and targeting a Glioblastoma cancer stem cell population with EGF Receptor Variant III.

K. Jensen, H. Vogel, Shuang-yin Han, 2013 .

Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma

Shuang-yin Han, J. Cui, A. Wong, 2013, Journal of Hematology & Oncology.

Generation of regulable EGFRvIII targeted chimeric antigen receptor T cells for adoptive cell therapy of glioblastoma.

Shuang-yin Han, A. Wong, Xiuling Li, 2018, Biochemical and biophysical research communications.

Enhancing proteasomal processing improves survival for a peptide vaccine used to treat glioblastoma

Brandon K. Vu, S. Skirboll, A. Wong, 2021, Science Translational Medicine.

Breast Cancer Prediction using varying Parameters of Machine Learning Models

Puja Gupta, Shruti Garg, S. Garg, 2020 .

IMMU-31. PROTEASOME REARRANGED PEPTIDES ARE A NOVEL SOURCE OF ANTIGENS FOR THE PEPTIDE VACCINE IMMUNOTHERAPY OF GLIOBLASTOMAS

S. Skirboll, A. Wong, Mario Fidanza, 2022, Neuro-Oncology.

A novel algorithm for mask detection and recognizing actions of human

Puja Gupta, S. Varma, Varsha Sharma, 2022, Expert Systems with Applications.

Association of mitochondrial calpain activation with increased expression and autolysis of calpain small subunit in an early stage of apoptosis.

K. Daniel, Q. Dou, Aslamuzzaman Kazi, 2003, International journal of molecular medicine.